Moderate-Intensity Rosuvastatin/Ezetimibe Combination versus Quadruple-Dose Rosuvastatin Monotherapy: A Meta-Analysis and Systemic Review

CONCLUSION: This meta-analysis showed that 5 mg rosuvastatin/10 mg ezetimibe had largely comparable lipid-modifying efficacy and tolerability as 20 mg rosuvastatin.PMID:38154476 | DOI:10.3349/ymj.2023.0285
Source: Yonsei Medical Journal - Category: Universities & Medical Training Authors: Source Type: research